v3.26.1
Interim Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2024
Cash flows from operating activities:      
Net loss $ (5,942) $ (1,252)  
Less: Net loss (income) from discontinued operations (6) 58  
Loss from continuing operations (5,948) (1,194)  
Adjustments to reconcile loss from continuing operations to net cash used in operating activities:      
Share-based compensation 513 150  
Change in fair value of convertible securities 326  
Effect of exchange rates (2) 6  
Change in operating assets and liabilities:      
Prepaid expenses and other current assets 108 88  
Accounts payable (483) 13  
Non- cash lease expense 14  
Operating lease liabilities (15)  
Accrued expense and other current liabilities (182) 178  
Cash used in operating activities from continuing operations (5,995) (433)  
Net cash used in operating activities from discontinued operations (41)  
Net cash used in operating activities (6,036) (433)  
Cash flows from investing activities:      
Short-term deposit (951)  
Purchase of property and equipment (4)  
Cash used in investing activities from continuing operations (955)  
Cash used in investing activities from discontinued operations  
Cash used in investing activities (955)  
Cash flows from financing activities:      
Proceeds from issuance of convertible securities (of which $0 and $50 are with related parties in 2026 and 2025, respectively) 435 $ 1,000
Payments in connection with initial public offering costs (55) (75)  
Proceeds from issuance of Ordinary Shares and Ordinary Warrants in a private placement, net 13,657    
Net cash provided by financing activities 13,602 360  
Cash used in financing activities from discontinued operations  
Net cash provided by financing activities 13,602 360  
Effect of exchange rate changes on cash, cash equivalents and restricted cash 2 (6)  
Net increase (decrease) in cash and cash equivalents 6,613 (79)  
Cash, cash equivalents and restricted cash at beginning of period 1,291 311  
Cash, cash equivalents and restricted cash at end of period 7,904 232 $ 311
Supplemental disclosure of non-cash financing activities:      
Offering cost included in accrued expense and other current liabilities 43  
Cash and cash equivalents 7,818 203  
Restricted cash 86 29  
Cash, cash equivalents and restricted cash at end of period $ 7,904 $ 232